Baker Bros. Advisors LP Edgewise Therapeutics, Inc. Transaction History
Baker Bros. Advisors LP
- $8.39 Billion
- Q1 2025
A detailed history of Baker Bros. Advisors LP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 6,155,940 shares of EWTX stock, worth $90.6 Million. This represents 1.61% of its overall portfolio holdings.
Number of Shares
6,155,940
Previous 6,155,940
-0.0%
Holding current value
$90.6 Million
Previous $164 Million
17.6%
% of portfolio
1.61%
Previous 1.82%
Shares
5 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$221 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$131 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$96.3 Million6.03% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$88.5 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75.35MShares$78.7 Million10.59% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $929M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...